125 related articles for article (PubMed ID: 28044264)
1. Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort.
Levi M; Prayogi G; Sastranagara F; Sudianto E; Widjajahakim G; Gani W; Mahanadi A; Agnes J; Khairunisa BH; Utomo AR
J Gastrointest Cancer; 2018 Jun; 49(2):124-131. PubMed ID: 28044264
[TBL] [Abstract][Full Text] [Related]
2. Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.
Zekri J; Al-Shehri A; Mahrous M; Al-Rehaily S; Darwish T; Bassi S; El Taani H; Al Zahrani A; Elsamany S; Al-Maghrabi J; Sadiq BB
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218784
[TBL] [Abstract][Full Text] [Related]
3. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH
Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686
[TBL] [Abstract][Full Text] [Related]
5. Association of folate intake, dietary habits, smoking and COX-2 promotor -765G>C polymorphism with K-ras mutation in patients with colorectal cancer.
Kamal MM; Youssef OZ; Lotfy AN; Elsaed ET; Fawzy MM
J Egypt Natl Canc Inst; 2012 Sep; 24(3):115-22. PubMed ID: 22929917
[TBL] [Abstract][Full Text] [Related]
6. Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.
Yoshino T; Muro K; Yamaguchi K; Nishina T; Denda T; Kudo T; Okamoto W; Taniguchi H; Akagi K; Kajiwara T; Hironaka S; Satoh T
EBioMedicine; 2015 Apr; 2(4):317-23. PubMed ID: 26137573
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.
Bai S; Feng Q; Pan XY; Zou H; Chen HB; Wang P; Zhou XL; Hong YL; Song SL; Yang JL
Int J Mol Med; 2017 Apr; 39(4):861-868. PubMed ID: 28259994
[TBL] [Abstract][Full Text] [Related]
8. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
Jin M; Long ZW; Yang J; Lin X
Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening of extended RAS mutations based on high-resolution melting analysis for prediction of anti-EGFR treatment efficacy in colorectal carcinoma.
Ishige T; Itoga S; Sato K; Kitamura K; Nishimura M; Sawai S; Matsushita K; Suzuki K; Ota S; Miyauchi H; Matsubara H; Nakatani Y; Nomura F
Clin Biochem; 2014 Dec; 47(18):340-3. PubMed ID: 25262986
[TBL] [Abstract][Full Text] [Related]
10. Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?
Allard MA; Saffroy R; de la Maisonneuve PB; Ricca L; Bosselut N; Hamelin J; Lecorche E; Bejarano MA; Innominato P; Sebagh M; Adam R; Morère JF; Lemoine A
Target Oncol; 2015 Sep; 10(3):415-21. PubMed ID: 25420993
[TBL] [Abstract][Full Text] [Related]
11. The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer: A National Study.
Cárdenas-Ramos SG; Alcázar-González G; Reyes-Cortés LM; Torres-Grimaldo AA; Calderón-Garcidueñas AL; Morales-Casas J; Flores-Sánchez P; De León-Escobedo R; Gómez-Díaz A; Moreno-Bringas C; Sánchez-Guillén J; Ramos-Salazar P; González-de León C; Barrera-Saldaña HA
Am J Clin Oncol; 2017 Jun; 40(3):274-276. PubMed ID: 25333735
[TBL] [Abstract][Full Text] [Related]
12. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study.
Brink M; de Goeij AF; Weijenberg MP; Roemen GM; Lentjes MH; Pachen MM; Smits KM; de Bruïne AP; Goldbohm RA; van den Brandt PA
Carcinogenesis; 2003 Apr; 24(4):703-10. PubMed ID: 12727799
[TBL] [Abstract][Full Text] [Related]
13. ["Field cancerization"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].
Aivado M; Gynes M; Gorelov V; Schmidt WU; Röher HD; Goretzki PE
Chirurg; 2000 Oct; 71(10):1230-4; discussion 1234-5. PubMed ID: 11077584
[TBL] [Abstract][Full Text] [Related]
14. Relationship between expression of ras p21 oncoprotein and mutation status of the K-ras gene in sporadic colorectal cancer patients in Tunisia.
Sammoud S; Khiari M; Semeh A; Amine L; Ines C; Amira A; Lilia K; Taher K; Sabeh M; Saadia B
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):146-52. PubMed ID: 21768877
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics, MSI and K-ras gene mutations of double primary malignancies associated with colorectal cancer].
Li Q; Zhang B; Niu FN; Ye Q; Chen J; Fan XS
Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(4):301-306. PubMed ID: 32075360
[No Abstract] [Full Text] [Related]
16. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
Gao J; Sun ZW; Li YY; Shen L
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
[TBL] [Abstract][Full Text] [Related]
17. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing.
Mack E; Stabla K; Riera-Knorrenschild J; Moll R; Neubauer A; Brendel C
BMC Cancer; 2016 Aug; 16():585. PubMed ID: 27485514
[TBL] [Abstract][Full Text] [Related]
18. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW
Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India.
Veldore VH; Rao MR; Prabhudesai SA; Tejaswi R; Kakara S; Pattanayak S; Krishnamoorthy N; Tejaswini BN; Hazarika D; Gangoli A; Rahman SM; Dixit J; Naik R; Diwakar RB; Satheesh CT; Shashidhara HP; Patil S; Gopinath KS; Kumar BS
Indian J Cancer; 2014; 51(4):531-7. PubMed ID: 26842186
[TBL] [Abstract][Full Text] [Related]
20. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
Karim B; Florence C; Kamel R; Nadia K; Ines O; Raja M; Sarra BJ; Florent S; Amel BA
Cancer Biomark; 2010-2011; 8(6):331-40. PubMed ID: 22072121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]